Ovarian Cancer: eMedicine Oncology
Links shared publicly online about this topic.
- 1,245total visits
Ovarian Cancer: eMedicine Oncology
View full resource at emedicine.medscape.com
Tags: Cancer, Ovarian Cancer, Disease and Condition, Women's Health, Oncology, Surgery
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
Medical News:%20Higher BMI Tied to Ovarian Cancer Risk - in Oncology/Hematology, Ovarian Cancer from MedPage Today
medpagetoday.com — “Medical News:%20Higher BMI Tied to Ovarian Cancer Risk - in Oncology/Hematology, Ovarian Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on April 6, 2012 at 9:48 pm By:
Higher BMI Tied to Ovarian Cancer Risk (CME/CE) http://t.co/NIekbGvp
Pox vaccines extend survival for patients with melanoma, ovarian cancer
medicalxpress.com — “An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology and Director of the Center for Immunotherapy at Roswell Park Cancer Institute ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 10:20 pm By:
PhysOrg Health News Health News
Pox vaccines extend survival for patients with melanoma, ovarian cancer http://t.co/nohDd8u7
Testosterone may play a role in treatment of triple negative breast cancer
news-medical.net — “Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 4:01 pm By:
Testosterone may play a role in treatment of triple negative breast cancer: Could blocking a testosterone recept... http://t.co/WXw6ppYW
Arch Dermatol -- Abstract: Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer, March 19, 2012, Girouard et al. 0 (2012): archdermatol.2012.288v1
archderm.ama-assn.org — “Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports and discussions that address the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery” View full resource at archderm.ama-assn.org
Most Recently Shared on March 20, 2012 at 12:41 pm By:
Panniculitis Associated With Dermatomyositis and Recurrent Ovarian Cancer [Observation]: Conclusions Although p... http://t.co/Uc8Yiazv
Oncology News - Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer |3982749
mdlinx.com — “Oncology Medical Article: Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on March 20, 2012 at 7:52 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian c... http://t.co/y4Q5ymYk #oncology
Oncology News - The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer |3978589
mdlinx.com — “Oncology Medical Article: The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 9:40 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer: British Journal... http://t.co/NC0FDD2d #oncology
Medical News:Specialized Care May Boost Cancer Survival - in Oncology/Hematology, Ovarian Cancer from MedPage Today
medpagetoday.com — “Medical News:Specialized Care May Boost Cancer Survival - in Oncology/Hematology, Ovarian Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2012 at 5:30 pm By:
Specialized Care May Boost Cancer Survival (CME/CE) http://t.co/TfRRhpME
Medical News:Specialized Care May Boost Cancer Survival - in Oncology/Hematology, Ovarian Cancer from MedPage Today
medpagetoday.com — “Medical News:Specialized Care May Boost Cancer Survival - in Oncology/Hematology, Ovarian Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on March 15, 2012 at 5:22 pm By:
Specialized Care May Boost Cancer Survival (CME/CE) http://t.co/MVXwGYnq
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies : The Lancet Oncology
thelancet.com — “Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. By - Dr Celeste Leigh Pearce PhD, Claire Templeman MD, Prof Mary An...” View full resource at thelancet.com
Most Recently Shared on March 15, 2012 at 10:37 am By:
Association between endometriosis & risk of ovarian cancer: analysis of case–control studies : The Lancet Oncology http://t.co/7OIlzpJ0
Beating the Odds | ASCO Connection
connection.asco.org — “Beating the Odds | ASCO Connection” View full resource at connection.asco.org
Most Recently Shared on March 12, 2012 at 7:40 pm By:
New #ASCOcommentary by Dr. Don Dizon: “Beating the Odds.” Read and comment here: http://t.co/GmzfmM6Q #cancer #oncology
Ovarian cancer – push for greater awareness
news-medical.net — “Women are being warned about ovarian cancer – mostly a silent killer, since many do not know what symptoms to look out for. Each year in the UK around 6,700 women are diagnosed with the disease and more than 4,000 women lose their lives.” View full resource at news-medical.net
Most Recently Shared on March 12, 2012 at 6:40 am By:
Ovarian Cancer News: Ovarian cancer – push for greater awareness: Women are being warned about ovarian cancer – ... http://t.co/VVpYUhp4
Access full year 2011 revenues increase 284%
news-medical.net — “ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology and cancer supportive care,announced preliminary revenue results for fourth quarter 2011 and full year 2011. Fourth quarter MuGard product sales increased 400% over third quarter product sales.” View full resource at news-medical.net
Most Recently Shared on March 5, 2012 at 3:42 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Access full year 2011 revenues increase 284%: ACCESS PHARMACEUTICALS, INC., a biopharmaceutical c... http://t.co/I6EmQBIl
Medical News:Ovarian Stem Cells Edge Closer to Reality - in Oncology/Hematology, Ovarian Cancer from MedPage Today
medpagetoday.com — “Medical News:Ovarian Stem Cells Edge Closer to Reality - in Oncology/Hematology, Ovarian Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on February 26, 2012 at 6:24 pm By:
Ovarian Stem Cells Edge Closer to Reality (CME/CE) http://t.co/WZBguNra
Rhei granted marketing approval for MuGard in China
news-medical.net — “ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.” View full resource at news-medical.net
Most Recently Shared on February 24, 2012 at 5:37 pm By:
Ovarian Cancer News: Rhei granted marketing approval for MuGard in China: ACCESS PHARMACEUTICALS, INC., a biopha... http://t.co/MZw6kyPE
FDA, pharmaceutical companies announce solution to cancer drug shortage
news-medical.net — “The U.S. Food and Drug Administration and several pharmaceutical companies said Tuesday they have reached agreements to alleviate shortages for the drugs methotrexate and Doxil. Methotrexate is used to treat children with a form of leukemia and others with tumors of the breast and lungs. Doxil is used to treat ovarian cancer and multiple myeloma.” View full resource at news-medical.net
Most Recently Shared on February 23, 2012 at 11:32 am By:
News-Medical.Net Oncology and Health News
Oncology News: FDA, pharmaceutical companies announce solution to cancer drug shortage: The U.S. Food and Drug A... http://t.co/Ef8u0xSI
Advertisement
